Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Letters: Observations

Forgot to Fast?

The importance on plasma glucose values

  1. Deborah J. Hilton, MPH1,
  2. Timothy A. Welborn, PHD2,
  3. Peter K. O’Rourke, PHD3 and
  4. Christopher M. Reid, PHD4
  1. 1Cardiovascular Disease Prevention Unit, Baker Medical Research Institute, Melbourne, Victoria, Australia
  2. 2Department of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia
  3. 3Queensland Centre for Public Health, The University of Queensland, Herston Qld, Australia
  4. 4Cardiovascular Disease Prevention Unit, Baker Medical Research Institute, Melbourne, Victoria, Australia
    Diabetes Care 2002 Nov; 25(11): 2112-2112. https://doi.org/10.2337/diacare.25.11.2112
    PreviousNext
    • Article
    • Info & Metrics
    • PDF
    Loading

    The importance on plasma glucose values

    We have recently shown that by using a casual plasma glucose value of >5.5 mmol/l as a cut point for screening, the yield of newly diagnosed diabetic subjects and those with impaired glucose tolerance (IGT) is greatly enhanced in comparison to using 6.5 or 7.5 mmol/l as cut-points for diagnostic assessment using the 1999 World Health Organization (WHO) criteria (1–3). In lowering this screening cut point for casual measurement, factors such as the time of eating before this test on the result may be relevant to its utility and warrant investigation.

    A total of 4,876 high-risk subjects, identified from 50,859 individuals participating in the Australian Diabetes Screening Study (1), provided fasting plasma glucose (FPG) and 2-h plasma glucose (2hPG) test results to confirm diabetes and IGT status. High risk was defined as having either two or more symptoms and/or two or more diabetes risk factors, casual plasma glucose values of >5.5 mmol/l, and no known diabetes (2). The time between when the subjects last ate and the casual plasma glucose test was calculated in minutes and grouped into hour blocks (0–360 min). Subjects were diagnosed as having diabetes or IGT using the 1999 WHO criteria (3).

    A casual plasma glucose of >5.5 mmol/l yielded a positive diagnosis of diabetes in 557 subjects (20%) and of IGT in 776 subjects (28%) >2 h after eating. Within 0–2 h of eating, the diagnostic yield of diabetes was less (316 subjects, −15%) but IGT rate similar (541 subjects, −26%). In subjects with risk factors for diabetes, a casual plasma glucose of >5.5 mmol/l generates a similar proportion of IGT cases irrespective of time since eating.

    Eating within 2 h of a casual glucose test in comparison to after 2 h resulted in a significantly higher level (7.09 ± 1.66 vs. 6.6 ± 1.38 mmol/l, respectively). However, if the screening cut point was raised for subjects who had consumed food within 2 h to 6.5 mmol/l, this would have yielded 249 (23%) diabetic subjects and 295 (25%) subjects with IGT. Raising the casual plasma glucose threshold to 7.5 mmol/l would yield 187 (33%) diabetic subjects and 157 (28%) subjects with IGT. Despite the fact that consuming food within 2 h of a casual glucose test results in significantly increased values, the 5.5 mmol/l cut point identified an additional 67 subjects (27%) with frank diabetes. It is also important to note that the 5.5 mmol/l cut point almost doubled the number of subjects with IGT in comparison to the 6.5 mmol/l cut-point, and the number tripled if 7.5 mmol/l was chosen as a cutoff.

    Thus the 5.5 mmol/l cut point seems to be valuable irrespective of the time since eating, as it results in early identification of subjects with IGT, which may aid in the prevention of the micro- and macrovascular complications associated with diabetes.

    Footnotes

    • Address correspondence to Dr. Christopher M. Reid, Cardiovascular Disease Prevention Unit, Baker Medical Research Institute, P.O. Box 6492, Melbourne, Victoria 8008. E-mail: chris.reid{at}baker.edu.au.

    • DIABETES CARE

    References

    1. ↵
      Welborn TA, Reid CM, Marriott G: Australian Diabetes Screening Study: impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Metabolism 46(Suppl. 1):35–39, 1997
      OpenUrlCrossRefPubMedWeb of Science
    2. ↵
      Hilton DJ, O’Rourke PK, Welborn TA, Reid CM: Diabetes detection in the Australian general practice setting: a comparison of different diagnostic criteria. MJA 176:104–107, 2002
    3. ↵
      World Health Organization (WHO): Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus Geneva Department of Noncommunicable Disease Surveillance, World Health Org., 1999 (Tech. Rep. Ser., no. 99.2)
    PreviousNext
    Back to top
    Diabetes Care: 25 (11)

    In this Issue

    November 2002, 25(11)
    • Table of Contents
    • About the Cover
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes Care.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Forgot to Fast?
    (Your Name) has forwarded a page to you from Diabetes Care
    (Your Name) thought you would like to see this page from the Diabetes Care web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Forgot to Fast?
    Deborah J. Hilton, Timothy A. Welborn, Peter K. O’Rourke, Christopher M. Reid
    Diabetes Care Nov 2002, 25 (11) 2112; DOI: 10.2337/diacare.25.11.2112

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Forgot to Fast?
    Deborah J. Hilton, Timothy A. Welborn, Peter K. O’Rourke, Christopher M. Reid
    Diabetes Care Nov 2002, 25 (11) 2112; DOI: 10.2337/diacare.25.11.2112
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Footnotes
      • References
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Weight Gain and Gestational Diabetes Mellitus Is a Sensitive Issue
    • Beneficial Effects of a 4-Week Exercise Program on Plasma Concentrations of Adhesion Molecules
    • Malignant Melanoma Misdiagnosed as a Diabetic Foot Ulcer
    Show more Letters: Observations

    Similar Articles

    Navigate

    • Current Issue
    • Standards of Care Guidelines
    • Online Ahead of Print
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.